Cell level diagnosis plays a significant role in the in vitro diagnostics (IVD) field. Cellular heterogeneity and changes carry the signatures of health and disease; therefore, cell-level diagnosis has been widely utilized for the detection of tumors. Powered by our advanced platforms and experienced experts in IVD development, Creative Biolabs is fully competent to provide high-quality cell-level diagnosis services to facilitate our clients' cancer research project development. We also serve as your reliable partner by tailoring the most appropriate solutions for cell-level diagnosis development.
Gene diagnosis, protein diagnosis, tissue diagnosis, and cell diagnosis, are four main categories in the field of IVD, according to the detection level. Cell level diagnosis, such as cell counting, monitoring, or flow cytometry test, can be used to monitor a person's overall health to help cure, treat, or prevent diseases. Especially, cell-level diagnosis may open new frontiers for detection and early prediction of tumors. More work is necessary to fully optimize clinical cell-level diagnosis and to improve the accuracy, specificity and sensitivity. Thinprep Cytologic Test (TCT) and CTC Detection are the most widely used in clinical practice in cell-level diagnosis.
TCT is a Liquid Based Cytology (LBC) method, which initiates changes in the way of fixation and production of slides which enhance dramatically the smear quality. It has been authorized to serve as a replacement to the conventional Papanicolaou test in 1996 by the Food and Drug Administration (FDA). TCT is intended for use in the screening and detection of cervical cancer, pre-cancerous lesions, atypical cells and all other cytologic categories as defined by the Bethesda system for reporting results of cervical cytology.
Circulating tumor cells (CTCs) are cancer cells that circulate in the bloodstream after being naturally shed from original or metastatic tumors. CTC detection is a liquid biopsy of tumors that can be used for early diagnosis of cancers, earlier evaluation of cancer recurrence, tumor prognosis, monitoring cancer progress and evaluation of chemotherapeutic efficacy, and developing individual sensitive anti-cancer drugs. It is a valuable tool in cell-level diagnosis.
Combined with the expertise and latest cell diagnosis technology, Creative Biolabs provides one-stop cell-level diagnosis services with high precision, sensitivity and flexibility. We have perfected our technical pipelines in the development of cell-level diagnosis for cancer research, especially TCT for cervical cancer and CTCs detection. Our platform facilitates both automated enrichment and flow cytometric analysis of circulating tumor cells, which allows the rapid and reproducible identification, quantification, and characterization of CTCs. Our platform prepares clearer and easier-to-read test slides to increase the racy for assessment of the tumor cells.
Cell-level diagnosis helps inform clinical decision making. If you are interested in our services, please feel free to contact us for more information.
For Research Use Only.